6-8 Bonhill Street
3rd Floor
London EC2A 4BX
United Kingdom
https://www.smallpharma.com
Sector(s):Â Healthcare
Industry:Â Biotechnology
Full Time Employees:Â
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. George Tziras | CEO & Non-Independent Director | 288.17k | N/A | N/A |
Mr. Peter David Rands | Chief Innovation & Intellectual Property Officer, Founder and Director | 338.95k | N/A | N/A |
Mr. David Steel | Chief Financial Officer | 281.27k | N/A | N/A |
Dr. Carol Routledge | Chief Scientific & Medical Officer | 351.9k | N/A | N/A |
Ms. Marie Claire Layzell | Chief Manufacturing & Devel. Officer & Director | 332.47k | N/A | N/A |
Dr. Alastair James Riddell M.D., M.Sc., MBChB, MFPM, MRCGP, MSc, Ph.D. | Chief Operating Officer | N/A | N/A | 1949 |
Mr. Richard M. Kimel HBA, LLB | Corp. Sec. | N/A | N/A | 1967 |
Mr. Jim Rennie | Director of Devel. and Member of Scientific & Advisory Board | N/A | N/A | N/A |
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company's clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. It is also developing a pipeline of proprietary preclinical assets. The company was founded in 2015 and is headquartered in London, the United Kingdom.
Small Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.